NFKB2 and breast cancer: Non-canonical NFkB2 signaling creates a slow, sustained activation of the pathway compared to rapid canonical signaling, but it has also been shown that p100 can sequester the canonical p50/p65 heterodimer in the cytoplasm in breast cancer [78].